Four Signs of Market Disruption in Biopharma—and How Brand Teams Can Stay Ahead
Biopharma brand teams often overlook early signals that their competitive position is weakening. The key is to recognize the warning signs—and act in time.
The latest insights, ideas, and perspectives from BCG. Explore a cross-section of up-to-date content on the trends shaping the future of business and society.
Biopharma brand teams often overlook early signals that their competitive position is weakening. The key is to recognize the warning signs—and act in time.
Sharon Marcil and Toni Townes Whitley explore bold leadership, building teams that last and leveraging AI to redefine innovation in today’s complex and rapidly evolving landscape.
Just months ago, many companies were skeptical about GenAI, but the focus now has shifted to integrating GenAI-enabled agents into teams, says BCG’s Vanessa Lyon.
HERE Technologies CEO Mike Nefkens shares insights on a new AWS partnership and the path to live maps in vehicles by 2026, in conversation with BCG’s Augustin Wegscheider.
Autonomous vehicles are on the move in several US cities. BCG’s Brian Collie reflects on two major CES announcements and the transformative potential of this technology.
BCG’s Rolf Kilian reflects on maturation in the automotive industry and highlights the importance of strategic focus for senior leaders.
BCG’s Lauren Taylor describes which topic is getting a lot of attention at the conference and why it matters to business leaders.
Less-than-truckload freight benefits from higher barriers to entry and other structural advantages over full-truckload freight, giving it solid pricing power and margin stability.